Acute heart failure
Information
- Disease name
- Acute heart failure
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04886128 | Active, not recruiting | Improving Diagnostic Accuracy for Acute Heart Failure | August 31, 2021 | June 30, 2025 | |
| NCT05518396 | Active, not recruiting | Prospective Validation of the CoDE-HF Algorithm for the Diagnosis of Acute Heart Failure | April 25, 2021 | August 31, 2024 | |
| NCT00348504 | Completed | Phase 3 | Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure. | March 2003 | June 2005 |
| NCT06024889 | Completed | Phase 1/Phase 2 | Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure. | September 1, 2023 | February 9, 2024 |
| NCT00498472 | Completed | Phase 4 | NT-proBNP in the Optimization of Treatment After Recent Acute Heart Failure Trial | July 2006 | April 2010 |
| NCT00512759 | Completed | Phase 4 | Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study | December 10, 2007 | February 21, 2019 |
| NCT00514384 | Completed | Serial Measurements of Biomarker in Patients With Acute Decompensated Heart Failure | February 2007 | December 2014 | |
| NCT00524433 | Completed | Phase 3 | Tezosentan in the Treatment of Acute Heart Failure | April 2003 | January 2005 |
| NCT00525707 | Completed | Phase 3 | Tezosentan in Acute Heart Failure | April 2003 | January 2005 |
| NCT00561483 | Completed | Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure | November 2007 | October 2014 | |
| NCT00568165 | Completed | N/A | EMEPIC : Value of a Mobile Team of Cardiologist Using Echocardiography for Managing Patients With Acute Heart Failure | February 2008 | July 2010 |
| NCT06012279 | Completed | Phase 4 | Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF) | August 1, 2023 | February 26, 2024 |
| NCT00911703 | Completed | Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely Sent Home (The DECIDE Study) | August 2008 | October 2015 | |
| NCT05710302 | Completed | Prospective Validation of the Emergency Heart Failure Mortality Risk Grade (EHMRG) Score in Patients With Acute Heart Failure in the Emergency Department | July 29, 2022 | January 24, 2023 | |
| NCT05410990 | Completed | Eosinophil Indices in Patients With Acute Heart Failure | January 2, 2017 | April 5, 2022 | |
| NCT05406505 | Completed | Phase 2/Phase 3 | Effect of Dapagliflozin in Patients With Acute Heart Failure (DAPA-RESPONSE-AHF) | April 25, 2022 | July 1, 2023 |
| NCT01080937 | Completed | French Observatory of Acute Heart Failure | March 2009 | February 2011 | |
| NCT01091441 | Completed | Permanent Observatory of Heart Failure | February 2007 | July 2014 | |
| NCT01127945 | Completed | N/A | Study to Evaluate the Effectiveness of High Dose Statin Loading in Acute Heart Failure Patients | May 2010 | November 2013 |
| NCT01132846 | Completed | Phase 2 | Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study | August 2010 | June 2013 |
| NCT01193998 | Completed | N/A | Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department | September 2010 | June 2014 |
| NCT05364190 | Completed | Phase 3 | Canagliflozin in Patients With Acute Decompansted Heart Failure | June 4, 2022 | December 1, 2023 |
| NCT01227317 | Completed | BIOmarkers of Dyspnea IN Emergency Room | April 2010 | September 2011 | |
| NCT05189119 | Completed | Use of PARniv for Early Diagnosis of LVF in AECOPD | January 3, 2022 | May 3, 2022 | |
| NCT05027360 | Completed | Sodium NItroPrusside Treatment in Acute Heart Failure | June 1, 2021 | November 23, 2021 | |
| NCT01363505 | Completed | Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters | May 2011 | April 2013 | |
| NCT01441245 | Completed | Phase 4 | Loop Diuretics Administration and Acute Heart Failure | April 2010 | December 28, 2017 |
| NCT01467973 | Completed | Gulf Acute Heart Failure Registry | February 2012 | November 2013 | |
| NCT01543854 | Completed | Phase 2 | Hemodynamic Responses to RLX030 Infusion in Subjects With Acute Heart Failure | March 2012 | January 2013 |
| NCT01614860 | Completed | Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels | May 2012 | June 2014 | |
| NCT01619540 | Completed | N/A | Valsalva Manœuvre in the Diagnosis of Left Ventricular Failure in Chronic Obstructive Pulmonary Disease Exacerbation | May 2011 | June 2013 |
| NCT04740242 | Completed | Metabolic Alkalosis in Heart Failure | January 1, 2021 | September 30, 2021 | |
| NCT04549701 | Completed | N/A | Inferior Vena CAVA and Lung UltraSound-guided Therapy in Acute Heart Failure | March 20, 2022 | February 28, 2023 |
| NCT04252404 | Completed | FranceLEVO - Zimino Registry (FZR) | February 3, 2020 | May 6, 2021 | |
| NCT01800968 | Completed | Phase 2 | Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) | April 2013 | October 2015 |
| NCT04245605 | Completed | Invasive Coronary Angiography Early in Ischemic Heart Failure | April 1, 2010 | September 30, 2021 | |
| NCT01834833 | Completed | N/A | Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient | May 2013 | July 2017 |
| NCT01870778 | Completed | Phase 3 | Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF | October 2, 2013 | February 1, 2017 |
| NCT01981655 | Completed | Phase 2 | 0.5M Na Lactate Solution in Acute Heart Failure (AHF) | December 2009 | August 2013 |
| NCT02002702 | Completed | Phase 2 | Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients | January 2014 | August 2014 |
| NCT03903198 | Completed | Care Pathways of Acute Heart Failure Patients: Impact on In-hospital Mortality. | June 2014 | October 2018 | |
| NCT02122640 | Completed | Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department | September 2012 | September 2013 | |
| NCT02135835 | Completed | Phase 4 | A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure | September 3, 2014 | March 24, 2017 |
| NCT02141607 | Completed | Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock | October 2014 | September 2017 | |
| NCT03806972 | Completed | Short and Long Term Prognosis of Patients Admitted to the ED With Acute Heart Failure | June 1, 2009 | October 1, 2021 | |
| NCT02157506 | Completed | Phase 2 | A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure | June 30, 2014 | July 31, 2015 |
| NCT02170961 | Completed | Study of Polymorphisms of RAAS and MMPs in Acute Heart Failure | February 2013 | December 2016 | |
| NCT03683212 | Completed | N/A | Early and Comprehensive Care Bundle in Elderly for Acute Heart Failure: a Stepped Wedge Cluster Randomized Trial | December 10, 2018 | November 12, 2019 |
| NCT03517514 | Completed | Heart Failure Hospital Readmissions and Physical Therapy | February 1, 2018 | August 28, 2019 | |
| NCT02350114 | Completed | N/A | An Observational Study of the Functional Capacity of Heart Failure | November 2014 | July 2015 |
| NCT03302910 | Completed | N/A | Short Stay Unit vs Hospitalization in Acute Heart Failure | December 6, 2017 | July 22, 2021 |
| NCT03243773 | Completed | Evaluation of Lung Ultrasound in Acute Heart Failure | March 1, 2016 | September 30, 2018 | |
| NCT02554890 | Completed | Phase 4 | Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode. | April 29, 2016 | July 24, 2018 |
| NCT03241069 | Completed | N/A | Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF) | July 2016 | December 2016 |
| NCT03234647 | Completed | N/A | First In Human Study of the Doraya Catheter for the Treatment of AHF Patients | January 1, 2018 | April 30, 2021 |
| NCT02728739 | Completed | N/A | Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients | June 6, 2016 | February 2018 |
| NCT03110042 | Completed | HILO-HF Registry: High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure | November 2016 | April 2019 | |
| NCT03048032 | Completed | Lithuanian Echocardiography Study of Dyspnea in Acute Settings | April 2015 | November 2018 | |
| NCT02877095 | Completed | Phase 1 | Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot | December 19, 2016 | November 7, 2017 |
| NCT02782572 | Completed | N/A | Safety of Aerobic Exercise in Acute Heart Failure | July 2010 | December 2011 |
| NCT06397404 | Completed | VExUS in Patients With Acute Heart Failure | May 18, 2023 | December 25, 2023 | |
| NCT06463964 | Enrolling by invitation | Predictors of Acute Kidney Injury in Patients With Acute Decompensated Heart Failure in Emergency | June 1, 2024 | December 1, 2024 | |
| NCT04062760 | Not yet recruiting | Phase 4 | Safety and Efficacy of Early, seQUential Oral dIuretic Nephron blockAde In Acute Heart Failure | December 1, 2019 | December 1, 2024 |
| NCT06203236 | Not yet recruiting | Phase 4 | Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease | January 2024 | November 2025 |
| NCT05865665 | Not yet recruiting | Registry Of Best Up-titration STrategies in Acute Heart Failure | June 2023 | December 2027 | |
| NCT06166654 | Not yet recruiting | Phase 4 | Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload | April 1, 2024 | March 31, 2027 |
| NCT05411991 | Recruiting | Phase 4 | Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment | June 12, 2022 | April 30, 2024 |
| NCT05392764 | Recruiting | Phase 3 | Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure | September 10, 2022 | June 30, 2025 |
| NCT05305495 | Recruiting | Phase 4 | Empagliflozin in Acute Heart Failure | December 22, 2022 | July 2025 |
| NCT05276219 | Recruiting | Phase 4 | Optimized Treatment of Pulmonary Edema or Congestion | September 14, 2023 | December 31, 2026 |
| NCT04829591 | Recruiting | A Multicenter Registry to Study the Characteristics and Outcomes of Jordanian Heart Failure Patients. | July 1, 2021 | December 30, 2024 | |
| NCT02444416 | Recruiting | Prospective Registry of Acute Heart Failure | December 2014 | November 2026 | |
| NCT03327532 | Recruiting | N/A | Acute Heart Failure - COngestion Repeated Evaluation (AHF-CORE) | February 13, 2018 | February 2026 |
| NCT06008197 | Recruiting | Phase 3 | A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients | January 17, 2024 | April 2026 |
| NCT06006819 | Recruiting | Prognostic Markers of Acute Heart Failure With Chronic Kidney Disease | January 1, 2023 | December 23, 2025 | |
| NCT06006754 | Recruiting | Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic Shock | August 30, 2023 | June 2024 | |
| NCT05991128 | Recruiting | Phase 4 | The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life | August 1, 2023 | August 1, 2025 |
| NCT05986773 | Recruiting | Phase 4 | Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance | October 10, 2023 | December 31, 2025 |
| NCT05972746 | Recruiting | N/A | Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure | October 7, 2022 | November 7, 2023 |
| NCT05971732 | Recruiting | Phase 4 | The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF) | August 1, 2023 | August 1, 2025 |
| NCT05962255 | Recruiting | Phase 3 | Sodium Chloride vs. Glucose Solute as a Volume Replacement Therapy During Decongestion in Acute Heart Failure | February 1, 2022 | May 2024 |
| NCT03793257 | Recruiting | The EXCEL Registry of Patients Requiring ECMO | February 1, 2019 | December 31, 2027 | |
| NCT06162247 | Recruiting | Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry) | November 20, 2023 | November 20, 2033 | |
| NCT03836079 | Recruiting | N/A | SVC Occlusion in Subjects With Acute Decompensated Heart Failure | July 31, 2019 | October 2024 |
| NCT05919225 | Recruiting | N/A | Risk Stratification Using MEESSI-AHF Scale in ED and Impact on AHF Outcomes | June 27, 2023 | December 31, 2024 |
| NCT06447467 | Recruiting | Short Term Outcome of Acute Heart Failure in Diabetic and Non Diabetic Patients | June 1, 2024 | December 1, 2024 | |
| NCT03999138 | Recruiting | MRI Assessment of Pulmonary Edema in Acute Heart Failure | January 2, 2019 | June 1, 2024 | |
| NCT04000061 | Recruiting | Heart Failure-USB: Prediction and Progression | June 13, 2019 | July 2027 | |
| NCT05916586 | Recruiting | N/A | Effect of Short-term Prednisone Therapy on C-reactive Protein in Patients With Acute Heart Failure | August 11, 2023 | October 2024 |
| NCT05871138 | Recruiting | Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure | March 30, 2023 | December 30, 2023 | |
| NCT02544815 | Recruiting | Phase 3 | Digoxin Short Term Treatment Assessment Randomized Trial in AHF | May 1, 2023 | July 31, 2025 |
| NCT04363697 | Recruiting | Phase 4 | Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68) | September 24, 2020 | March 2024 |
| NCT04442555 | Recruiting | Phase 1 | Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Acute Heart Failure | February 1, 2020 | March 30, 2023 |
| NCT05461547 | Recruiting | N/A | Pre-Hospital Lung Ultrasound Impact on Diagnosis | February 9, 2023 | February 2024 |
| NCT04481919 | Recruiting | Phase 2 | Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE) | May 1, 2022 | December 31, 2026 |
| NCT05556044 | Recruiting | Phase 3 | Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction | September 27, 2022 | May 31, 2024 |
| NCT05809011 | Recruiting | Phase 2/Phase 3 | Efficacy and Safety of corticoSTEROids Added to Standard Therapy in Patients With Acute Heart Failure (STERO-AHF) | April 24, 2023 | December 2025 |
| NCT05668676 | Recruiting | Phase 2/Phase 3 | Effect of Short-Term Prednisone Therapy on C-Reactive Protein Change in Emergency Department Patients With Acute Heart Failure and Elevated Inflammatory Markers ( CORTAHF ) | February 16, 2023 | March 2024 |
| NCT05613218 | Recruiting | Phase 2/Phase 3 | Oxygen Targets in Acute Heart Failure With Pulmonary Congestion | February 1, 2024 | August 31, 2025 |
| NCT04329234 | Recruiting | Korean Heart Failure Registry III | October 1, 2018 | December 31, 2027 | |
| NCT05586048 | Recruiting | Effectiveness of Yiqi Fumai Lyophilized Injection for Acute Heart Failure | April 1, 2023 | November 30, 2025 | |
| NCT04332692 | Recruiting | N/A | Acute Heart Failure - COngestion Discharge Evaluation | July 15, 2020 | May 20, 2028 |
| NCT04343430 | Recruiting | N/A | Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation | August 29, 2020 | August 29, 2028 |
| NCT04343443 | Recruiting | N/A | Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation | August 21, 2020 | August 21, 2028 |
| NCT03736421 | Suspended | Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients | November 10, 2018 | April 2021 | |
| NCT02769351 | Terminated | Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration | December 3, 2015 | March 4, 2019 | |
| NCT03161158 | Terminated | N/A | PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure | November 3, 2017 | August 26, 2019 |
| NCT03170219 | Terminated | Phase 2 | Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study | April 27, 2018 | September 20, 2018 |
| NCT02595814 | Terminated | Global Non-interventional Heart Failure Disease Registry | July 23, 2014 | March 31, 2018 | |
| NCT03554200 | Terminated | Phase 2 | EMPA Acute Heart Failure | June 11, 2018 | October 29, 2020 |
| NCT03621436 | Terminated | N/A | Clinical Evaluation of the TRVD™ System in ADHF | August 7, 2015 | May 2019 |
| NCT02151383 | Terminated | Phase 2 | Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure | September 5, 2014 | April 3, 2017 |
| NCT02007720 | Terminated | Phase 3 | Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF | March 12, 2014 | June 16, 2017 |
| NCT04174794 | Terminated | Investigating Reduction of aCute heArt Failure Readmission With Lung UltraSound-preliminary Trial | October 8, 2019 | March 16, 2020 | |
| NCT01615926 | Terminated | Assessment of The Clinical Course of Dyspnea in Acute Heart Failure Patients | June 2012 | August 2012 | |
| NCT01301313 | Terminated | Phase 2 | Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children | February 2011 | February 2012 |
| NCT01264159 | Terminated | N/A | Preemptive Lung Impedance-guided Therapy of Evolving Acute Heart Failure in Acute Myocardial Infarction Patients | January 1, 2011 | July 1, 2015 |
| NCT01067859 | Terminated | Phase 2 | A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF) | March 2010 | November 2010 |
| NCT01065077 | Terminated | Phase 2 | BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF) | March 2010 | February 2011 |
| NCT00449423 | Terminated | Phase 2 | Metabolic Modulation as Treatment in Acute Heart Failure | March 2007 | October 2007 |
| NCT00221819 | Terminated | N/A | Gases Humidification During Noninvasive Ventilation : Heat and Moisture Exchanger or Heated Humidifier ? | June 2004 | December 2004 |
| NCT00083772 | Terminated | Phase 4 | Use of Nesiritide in the Management of Acute Diastolic Heart Failure | May 17, 2004 | April 24, 2006 |
| NCT04694092 | Unknown status | N/A | Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation | November 5, 2020 | December 31, 2023 |
| NCT01211886 | Unknown status | Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU) | September 2010 | ||
| NCT04900584 | Unknown status | N/A | Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure. | June 23, 2020 | February 28, 2023 |
| NCT02638142 | Unknown status | Loop Diuretic Therapy in Acutely Decompensated Heart Failure | December 2015 | December 2020 | |
| NCT05090930 | Unknown status | N/A | Innovative Technologies for the Treatment of Pulmonary and Heart Failure | January 1, 2021 | December 1, 2023 |
| NCT03189901 | Unknown status | Phase 4 | Early Management Strategies of Acute Heart Failure for Patients With NSTEMI | July 1, 2017 | December 31, 2021 |
| NCT04633629 | Unknown status | LUS in Acute Heart Failure Therapeutic Adaptation | December 2020 | October 2021 | |
| NCT03157219 | Unknown status | Manipal Heart Failure Registry (MHFR) | September 10, 2015 | May 31, 2019 | |
| NCT01704131 | Unknown status | Levosimendan Pharmacokinetics in Children | November 2012 | September 1, 2019 | |
| NCT04465123 | Unknown status | Phase 3 | Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study | August 13, 2020 | December 31, 2022 |
| NCT00937092 | Unknown status | Phase 4 | Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial | January 2009 | July 2012 |
| NCT04405804 | Unknown status | Phase 2 | Early Administration of Ivabradine in Children With Heart Failure | June 20, 2020 | May 2021 |
| NCT04331132 | Unknown status | N/A | Tolvaptan add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction | December 1, 2021 | July 26, 2023 |
| NCT04252937 | Unknown status | Phase 2 | Adrecizumab Dose Escalation Safety and Tolerability Evaluation (ADESTE) | December 15, 2019 | March 31, 2022 |
| NCT01733134 | Unknown status | Phase 3 | Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE) | January 2013 | December 2014 |
| NCT01822808 | Unknown status | Phase 3 | Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure | January 2013 | July 2016 |
| NCT04240067 | Unknown status | Multimarker Approach for Acute Dyspnea in Elderly Patients Admitted in the Emergency Department | June 1, 2018 | December 2022 | |
| NCT04163588 | Unknown status | Phase 3 | Sequential Nephron Blockade in Acute Heart Failure | October 1, 2019 | December 31, 2020 |
| NCT04146701 | Unknown status | Metabolomics and Microbiomics in Cardiovascular Diseases | February 1, 2019 | December 31, 2022 | |
| NCT03892148 | Unknown status | Phase 4 | Protocol of Diuretics Use in Congestive Therapy in Heart Failure | May 17, 2019 | December 2021 |
| NCT03720288 | Unknown status | Phase 3 | Acetazolamide in Patients With Acute Heart Failure | October 1, 2018 | October 1, 2020 |
| NCT03717636 | Unknown status | N/A | Early or Non-revoked in Hospital-day in Patients With Acute Heart Failure | October 1, 2018 | October 1, 2021 |
| NCT03696875 | Unknown status | N/A | Discharge Planning in Emergency Department for Frail Older With AHF | May 20, 2019 | May 15, 2022 |
| NCT02258984 | Unknown status | N/A | Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial | October 2014 | December 2015 |
| NCT03681379 | Unknown status | Pharmacokinetics of Levosimendan in Pediatric Intensive Care Units | October 1, 2018 | October 1, 2020 | |
| NCT03508505 | Unknown status | Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation | January 1, 2018 | December 31, 2020 | |
| NCT03490994 | Unknown status | Phase 4 | Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF) | April 10, 2018 | January 2020 |
| NCT00692718 | Unknown status | Phase 4 | N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure | July 2008 | |
| NCT01625403 | Unknown status | Phase 2 | Recombinant BNP on Heart and Renal Function in Acute Heart Failure | July 2012 | December 2013 |
| NCT04698005 | Unknown status | Phase 3 | Exogenous Ketones for Acutely Decompensated HEart Failure | December 2, 2020 | December 31, 2021 |
| NCT04592380 | Withdrawn | Phase 3 | Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF | August 2014 | November 2016 |
| NCT06181968 | Withdrawn | N/A | Ultrasound-guided Treatment in Acute Heart Failure | March 13, 2019 | November 30, 2020 |
| NCT02299726 | Withdrawn | Phase 2 | Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study | May 2015 | November 2018 |
| NCT02767024 | Withdrawn | Phase 4 | Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure | May 1, 2018 | June 1, 2018 |
| NCT00922402 | Withdrawn | N/A | Heart & Diabetes - Feasibility Study | June 2009 | September 2011 |